Vaxxinity Reports Fourth Quarter and Full-Year 2022

CAPE CANAVERAL, Fla., March 27, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of...

Related Keywords

Belgium ,Australia ,Texas ,United States ,Dallas ,Florida ,United Kingdom ,Greg Blatt ,Katherine Eade ,Gaby Toledano ,Acta Neuropathologica ,Mark Joinnides ,James Smith ,James Chui ,Landon Ogilvie ,Movement Disorders ,Frontier Exploration Laboratory ,Company Annual Report On Form ,Nasdaq ,Exchange Commission On ,Coalition For Epidemic Preparedness Innovations ,Vaxxinity Inc ,Cape Canaveral ,Recent Clinical Pipeline ,Track Designation ,Epidemic Preparedness Innovations ,Infectious Diseases ,Emerging Microbes ,Recent Corporate ,Year End ,United Neuroscience ,Private Securities Litigation Reform Act ,Annual Report ,Exchange Commission ,Nasdaq Vaxx ,Vaxxinity ,Nc ,